FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders.
Lui A, Vanleuven J, Perekopskiy D, Liu D, Xu D, Alzayat O, Elgokhy T, Do T, Gann M, Martin R, Liu DZ.
Lui A, et al. Among authors: perekopskiy d.
Pharmaceuticals (Basel). 2022 Dec 13;15(12):1546. doi: 10.3390/ph15121546.
Pharmaceuticals (Basel). 2022.
PMID: 36558997
Free PMC article.
Review.